SCHEMBL4628111

SCHEMBL4628111

CCCOCCCc1cc2c(=O)n(NS(C)(=O)=O)c(=O)[nH]c2cc1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DDR1 Q08345 13/20 0.36
AR P10275 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4627637 0.88 DDR1 (0.37) DDR1AR
SCHEMBL4628778 0.87 TSHR (0.36) DDR1
SCHEMBL4628707 0.85 DDR1 (0.37) DDR1AR
SCHEMBL4627649 0.83 CA12 (0.38) DDR1AR
SCHEMBL2391466 0.81 DDR1 (0.38) DDR1AR
SCHEMBL2390017 0.81 DDR1 (0.38) DDR1AR
SCHEMBL958028 0.78 DDR1 (0.35) DDR1AR
SCHEMBL2389873 0.78 DDR1 (0.41) DDR1
SCHEMBL2388699 0.75 PARP1 (0.44) DDR1AR
SCHEMBL1661191 0.74 DDR1 (0.35) DDR1AR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1871749-A1 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS Novartis AG (US) 2008-01-02 EP disclosed
WO-2006108591-A1 1H-QUINAZ0LINE-2,4-DIONES AND THEIR USE AS AMPA-RECEPTOR LIGANDS NOVARTIS AG (CH) 2006-10-19 WO disclosed